Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.
종목 코드 GNFT
회사 이름Genfit SA
상장일Dec 19, 2006
CEOMr. Pascal Prigent
직원 수180
유형Ordinary Share
회계 연도 종료Dec 19
주소Parc Eurasante 885 avenue Eugene Avinee
도시LOOS
증권 거래소Euronext Paris
국가France
우편 번호59120
전화33320164000
웹사이트https://www.genfit.fr/
종목 코드 GNFT
상장일Dec 19, 2006
CEOMr. Pascal Prigent
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음